Etoposide Injection
Product Images NDC 68001-265

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Etoposide (NDC 68001-265). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bluepoint Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Etoposide Inj Carton .jpg (Etoposide Inj Carton Label 100mg 5ml (20mg mL) Rev 1114)

The text contains information about Etoposide Injection USP with a strength of 100mg/ml. The rest of the text is not coherent or readable.*

FDA Label Image

Etoposide Inj Vial Label.jpg (Etoposide Inj Vial Label 100mg 5ml (20mg mL) Rev1114)

This is a description of a medication called Etoposide containing 20mg of USP with specific detailed compositions of the product. It provides a usual dosage, instructions for use, precautions, and storage temperatures. It was manufactured in India and must be diluted before IV infusion. This is a cytotoxic agent and is intended for Rx Only. Lot and EXP or 2D matrix are also mentioned.*

FDA Label Image

Etoposide Structural Formula (Etoposide Struc)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.